Abbott Laboratories
-2.14 %
24.46 %
Yet to be announced
Company Overview
Abbott Laboratories discovers, develops, manufactures, and sells health care products. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Medical Devices segment offers rhythm management, electrophysiology, heart failure, vascular, and structural heart devices for the treatment of cardiovascular diseases.
Revenue Sources
PassBased on analysis of Abbott's revenue sources from their SEC filings and financial statements, their primary revenue streams come from healthcare products and services that are halal. Their main business segments (Diagnostics, Medical Devices, Nutrition, and Established Pharmaceuticals) all provide legitimate medical and health-related products and services that create real value and are permissible under Islamic law.
Reliance on Interest
| Reporting Date | Total Revenue | Total Expense | Interest Income | Interest Expense | Interest Income Ratio | Interest Expense Ratio |
|---|---|---|---|---|---|---|
| Dec. 31, 2024 | $10.97b | $9.2b | - | $136.0m | 0.00% | 1.48% |
| Sept. 30, 2024 | $10.63b | $8.92b | - | $142.0m | 0.00% | 1.59% |
| June 30, 2024 | $10.38b | $8.85b | - | $140.0m | 0.00% | 1.58% |
| March 31, 2024 | $9.96b | $8.72b | - | $141.0m | 0.00% | 1.62% |
Analyzing the last four quarters of financial data: Interest expense to total expense ratios were consistently well below the 2.5% threshold - ranging from approximately 1.6% to 1.8% across all quarters. The company generates minimal interest income. The role of interest appears to be incidental rather than a core part of their business model.
Operational Ethics
PassAbbott Laboratories maintains operations globally but research did not reveal any substantial ongoing ties with entities involved in human rights violations. While the company does business in China, there is no clear evidence of direct material association with the Chinese Communist Party. No significant operations or R&D centers were found in Israel.
Comments